Welocalize Evolves its Branding to Better Align to its Clients

The new structure introduces Welo Global as the parent, with Welocalize, Adapt, Park IP, Welo Data, and a new brand - Welo Life Sciences - as brands aligned to client segments.

WELOCALIZE, INC. — NEW YORK — 07 April 2026  — Welo Global today launched as the new parent brand overseeing a portfolio of brands aligned to specific customer segments, including Welocalize, Welo Data, Park IP, and Adapt. It also introduced Welo Life Sciences, a dedicated brand focused on serving life sciences organizations.

This evolution aligns the company’s branding with its strategy and direction. Over the last two years, the company has been on a pathway of organizing the business around client segments and developing specialized solutions and expertise to better serve them. Further, as enterprises adopt AI systems, they require partners with specialized capabilities rather than generalized solutions.

“Today, most of our clients and revenue come from outside the localization function,” said Paul Carr, CEO of Welo Global. “They include marketing teams, legal departments, clinical organizations, and AI research labs. A single brand built around localization no longer reflects our business or our direction. Welo Global embodies our shared values and strength in multilingual while allowing each client brand to focus on the specific customers it serves.”

Under the Welo Global umbrella, each client brand develops and maintains its own positioning, solutions, expertise, technology, and go-to-market focus: 

• Welocalize delivers multilingual solutions for localization functions and technology departments, powered by advanced AI-enabled workflows through its Opal system.
• Adapt is a multilingual marketing agency supporting global marketing, SEO, digital performance, and content strategy, with Adapt Studio providing a centralized environment for managing multilingual marketing workflows and campaigns.
• Park IP provides patent translation, foreign filing, and legal solutions for in-house legal teams and law firms, supported by its Legal Studio for managing global IP workflows.
• Welo Life Sciences is a new brand that specializes in multilingual content solutions for drug and medical device development for pharmaceutical, contract research, and medical device organizations.
• Welo Data specializes in multilingual data sets for foundation model builders and research labs to support AI development via data generation, RLHF, and model evaluation, including its NIMO platform for workforce identity management.

Together, Welo Global’s brands deliver differentiated solutions to more than 2,000 clients in over 300 languages certified to 7 ISO Standards in industries including technology, manufacturing, life sciences, legal, and consumer.

Each brand has its own website that speaks directly to its clients, all accessible from the Welo Global website. Each brand is overseen by a General Manager and combines the client delivery, commercial, marketing, product and technology teams to ensure that the value propositions, solutions, and operational performance are resonant with the unique needs of its clients.

Welo Global is committed to ensuring its global workforce of over 500,000 linguists and domain experts can access opportunities across all client brands through the Welo Global website, supported by upskilling in specialties aligned to specific client needs.

Learn more about Welo Global at weloglobal.com.

About Welo Global

Welo Global is a leader in multilingual AI, technology, and content solutions serving over 2,000 clients in 300 languages. The company combines globally scaled multilingual infrastructure, including a network of over 500,000 linguists and domain experts, with advanced NLP, computational linguistics, and best-in-class compliance backed by seven ISO certifications. Welo Global’s five brands—Welocalize (multilingual content and localization solutions for localization and technology teams), Adapt (multilingual performance-led digital marketing agency), Park IP (patent translation, foreign filing, and legal solutions for law firms and corporate legal teams), Welo Life Sciences (multilingual content solutions for drug and medical device development for pharmaceutical, contract research, and medical device organizations), and Welo Data (multilingual data generation, evaluation, and human data infrastructure for AI systems)—serve distinct customer segments with purpose-built expertise, solutions, and technology. weloglobal.com